A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2011

Conditions

Renal Impairment

Interventions

DRUG

fimasartan

single administration of fimasartan 120mg

Trial Locations (1)

Seoul National University Hospital, Seoul